RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target

Tumor heterogeneity results in differential response to therapy due to the existence of plastic tumor cells, called cancer stem cells (CSCs), which exhibit the property of resistance to therapy, invasion and metastasis. These cells have a distinct, signaling network active at every stage of progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Pavana, Pranatharthi, Annapurna, Ross, Cecil, Srivastava, Sweta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651989/
https://www.ncbi.nlm.nih.gov/pubmed/31340863
http://dx.doi.org/10.1186/s13046-019-1327-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651989/
https://www.ncbi.nlm.nih.gov/pubmed/31340863
http://dx.doi.org/10.1186/s13046-019-1327-4

Ejemplares similares